Literature DB >> 9259374

Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians.

D Goldman1, M Urbanek, D Guenther, R Robin, J C Long.   

Abstract

Alcoholism is one of a group of common psychiatric diseases which are well-defined clinically and strongly influenced genetically, but which are likely to be highly heterogeneous in causation, genetically and otherwise. Dopamine is a key neurotransmitter in drug-mediated reinforcement. Based on association studies with the Taq1A downstream marker, the D2 dopamine receptor has been proposed to be the "Reward Deficiency Syndrome Gene." Ser311Cys, a naturally occurring variant which largely inactivates transduction after D2 receptor activation, was abundant (0.16) in a Southwestern American Indian population we studied. Therefore, we were able to provide a critical test of the D2 hypothesis of vulnerability to alcoholism by evaluating Ser311Cys and also the intron-2 STR and Taq1A markers at this locus in a total of 459 subjects, including 373 sib pairs, from large families. The result is that neither alcoholism, substance use disorders nor schizophrenia show a relationship to Ser311Cys genotype, even when the 15 Cys311/Cys311 homozygous individuals are compared to others. Furthermore, sib pair analysis incorporating information across all three sib pair categories: concordant affected, discordant and concordant unaffected revealed no effect of DRD2 genotype or haplotype on alcoholism or substance use disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259374     DOI: 10.1002/(sici)1096-8628(19970725)74:4<386::aid-ajmg9>3.0.co;2-n

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

Review 1.  The genetics of alcoholism and alcohol abuse.

Authors:  M A Enoch; D Goldman
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

2.  A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence.

Authors:  Fan Wang; Arthur Simen; Albert Arias; Qun-Wei Lu; Huiping Zhang
Journal:  Hum Genet       Date:  2012-12-01       Impact factor: 4.132

3.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

4.  The association between DRD2/ANKK1 and genetically informed measures of alcohol use and problems.

Authors:  Jacquelyn L Meyers; Emma Nyman; Anu Loukola; Richard J Rose; Jaakko Kaprio; Danielle M Dick
Journal:  Addict Biol       Date:  2012-09-12       Impact factor: 4.280

5.  The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.

Authors:  Stephen J Glatt; Erik G Jönsson
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

Review 6.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

Review 7.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

8.  Drd2 expression in the high alcohol-preferring and low alcohol-preferring mice.

Authors:  Paula J Bice; Tiebing Liang; Lili Zhang; Wendy N Strother; Lucinda G Carr
Journal:  Mamm Genome       Date:  2008-01-23       Impact factor: 2.957

9.  Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.

Authors:  Claudio A Naranjo; Alan Y Chu; Lescia K Tremblay
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

10.  The ANKK1 kinase gene and psychiatric disorders.

Authors:  Guillermo Ponce; Rocío Pérez-González; María Aragüés; Tomás Palomo; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Janet Hoenicka
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.